IL-7 primes IL-17 in mucosal-associated invariant T (MAIT) cells, which contribute to the Th17-axis in ankylosing spondylitis
E Gracey, Z Qaiyum, I Almaghlouth… - Annals of the …, 2016 - ard.bmj.com
Objective Ankylosing spondylitis (AS) is a chronic inflammatory disease of unknown origin
in which interleukin (IL) 17 has been genetically and therapeutically recognised as a key …
in which interleukin (IL) 17 has been genetically and therapeutically recognised as a key …
A unique presentation of delirium in a patient with otherwise asymptomatic COVID‐19
WA Alkeridy, I Almaghlouth, R Alrashed… - Journal of the …, 2020 - Wiley Online Library
… Alkeridy and Ibrahim Almaghlouth contributed equally to this manuscript and are co-first
authors.Address correspondence to Walid A. Alkeridy, Department of Medicine, King Saud …
authors.Address correspondence to Walid A. Alkeridy, Department of Medicine, King Saud …
Impact of COVID‐19 outbreak on rheumatic patients' perceptions and behaviors: A cross‐sectional study
LM Hassen, IA Almaghlouth, IM Hassen… - … journal of rheumatic …, 2020 - Wiley Online Library
Aim The dynamics of coronavirus disease 2019 (COVID‐19) pandemic has become of special
concern to the rheumatology community. Rheumatic patients are required to engage in …
concern to the rheumatology community. Rheumatic patients are required to engage in …
IL-22 contributes to TGF-β1-mediated epithelial-mesenchymal transition in asthmatic bronchial epithelial cells
…, M Nishioka, J Chakir, PA Risse, I Almaghlouth… - Respiratory …, 2013 - Springer
Background Allergic asthma is characterized by airway inflammation in response to antigen
exposure, leading to airway remodeling and lung dysfunction. Epithelial-mesenchymal …
exposure, leading to airway remodeling and lung dysfunction. Epithelial-mesenchymal …
Changes in healthcare workers' knowledge, attitudes, practices, and stress during the COVID-19 pandemic
…, A Alhaboob, A Alsalmi, W AlMuhanna, I Almaghlouth… - Medicine, 2021 - journals.lww.com
Coronavirus disease 2019 (COVID-19) has caused an unprecedented health crisis around
the world, not least because of its heterogeneous clinical presentation and course. The new …
the world, not least because of its heterogeneous clinical presentation and course. The new …
[HTML][HTML] Clinical and biochemical characteristics of people experiencing post-coronavirus disease 2019-related symptoms: A prospective follow-up investigation
…, K Siddiqui, A Youssef, H Altalhi, I Almaghlouth… - Frontiers in …, 2022 - frontiersin.org
Background Post-acute COVID-19 syndrome, also known as long COVID, is a prolonged
illness after the acute phase of COVID-19. Hospitalized patients were known to have persisting …
illness after the acute phase of COVID-19. Hospitalized patients were known to have persisting …
Immediate effect of the COVID-19 pandemic on patient health, health-care use, and behaviours: results from an international survey of people with rheumatic diseases
…, ST Angeles-Han, IA Almaghlouth… - The Lancet …, 2021 - thelancet.com
Background The impact and consequences of the COVID-19 pandemic on people with
rheumatic disease are unclear. We developed the COVID-19 Global Rheumatology Alliance …
rheumatic disease are unclear. We developed the COVID-19 Global Rheumatology Alliance …
[HTML][HTML] Development and implementation of the AIDA international registry for patients with VEXAS syndrome
Objective: The aim of this paper is to present the AutoInflammatory Disease Alliance (AIDA)
international Registry dedicated to Vacuoles, E1 enzyme, X-linked, Autoinflammatory, …
international Registry dedicated to Vacuoles, E1 enzyme, X-linked, Autoinflammatory, …
Venous thromboembolism in rheumatoid arthritis: the added effect of disease activity to traditional risk factors
…, AM Boudal, MK Bedaiwi, I Almaghlouth - Open Access …, 2022 - Taylor & Francis
Many epidemiological studies have shown an increased risk of venous thromboembolism (VTE)
in patients with rheumatoid arthritis (RA). RA and VTE share some background factors, …
in patients with rheumatoid arthritis (RA). RA and VTE share some background factors, …
[HTML][HTML] The administration of methotrexate in patients with Still's disease,“real-life” findings from AIDA Network Still Disease Registry
…, IP de Brito Antonelli, I Almaghlouth… - Seminars in arthritis and …, 2023 - Elsevier
Objectives To describe clinical characteristics of patients with Still's disease treated with
methotrexate (MTX) and to assess drug effectiveness evaluating change in disease activity, …
methotrexate (MTX) and to assess drug effectiveness evaluating change in disease activity, …
